|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 89, 97-106, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
FR Kuntschen, PM Galletti, C Hahn, JJ Arnulf, C Isetta and V Dor
Anesthesia, surgical trauma, heparinization, priming volume composition,
and temperature control of the heart-lung machine individually affect
carbohydrate, protein, or lipid metabolism during cardiac operations. The
impact of some of these factors on glucose and insulin regulation was
assessed before, during, and after normothermic cardiopulmonary bypass in
nondiabetic patients with use of a servo- controlled insulin delivery
system. With a glucose-free prime, cardiopulmonary bypass induced a slight
hyperglycemia but no endogenous insulin response, suggesting a partial
inhibition of insulin secretion. Nonetheless, insulin release could be
stimulated by exogenous glucagon. A glucose load in the priming fluid led
to marked and persistent hyperglycemia without commensurate insulin
release. Elevated stress hormone levels, a concomitant reduction of insulin
release and insulin action, and a depression of peripheral glucose
utilization, as demonstrated by glucose clamp experiments, contributed to
these perturbations of glucose and insulin metabolism. Although the
metabolic alterations observed are not critical in routine cardiac
operations, they may become clinically significant in postoperative states
with unusual persistence of stress conditions.
ARTICLES
Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia
This article has been cited by other articles:
![]() |
G. Carvalho, A. Moore, B. Qizilbash, K. Lachapelle, and T. Schricker Maintenance of Normoglycemia During Cardiac Surgery Anesth. Analg., August 1, 2004; 99(2): 319 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Maillet, P. Le Besnerais, M. Cantoni, P. Nataf, A. Ruffenach, A. Lessana, and D. Brodaty Frequency, Risk Factors, and Outcome of Hyperlactatemia After Cardiac Surgery Chest, May 1, 2003; 123(5): 1361 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Gustafson, D. L Zarro, D. A Palanzo, N. J Manley, R. M Montesano, M. Quinn, B.-A. Elmore, and J. M Castagna Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery Perfusion, March 1, 2002; 17(2): 141 - 144. [Abstract] [PDF] |
||||
![]() |
K. S. Bandali, M. P. Belanger, and C. Wittnich Is hyperglycemia seen in children during cardiopulmonary bypass a result of hyperoxia? J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Conroy, M. R. Grafe, L. W. Jenkins, A. H. Vela, C. Y. Lin, D. S. DeWitt, and W. E. Johnston Histopathologic consequences of hyperglycemic cerebral ischemia during hypothermic cardiopulmonary bypass in pigs Ann. Thorac. Surg., April 1, 2001; 71(4): 1325 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wittnich, S. M. Torrance, and C. E. Carlyle Effects of hyperoxia on neonatal myocardial energy status and response to global ischemia Ann. Thorac. Surg., December 1, 2000; 70(6): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Cook Changing Temperature Management for Cardiopulmonary Bypass Anesth. Analg., June 1, 1999; 88(6): 1254 - 1254. [Full Text] [PDF] |
||||
![]() |
H. Braden, S. Cheema-Dhadli, C. D. Mazer, D. J. McKnight, W. Singer, and M. L. Halperin Hyperglycemia During Normothermic Cardiopulmonary Bypass: The Role of the Kidney Ann. Thorac. Surg., June 1, 1998; 65(6): 1588 - 1593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |